[go: up one dir, main page]

WO2022165696A1 - Composition pour améliorer l'aspect de matières kératiniques - Google Patents

Composition pour améliorer l'aspect de matières kératiniques Download PDF

Info

Publication number
WO2022165696A1
WO2022165696A1 PCT/CN2021/075212 CN2021075212W WO2022165696A1 WO 2022165696 A1 WO2022165696 A1 WO 2022165696A1 CN 2021075212 W CN2021075212 W CN 2021075212W WO 2022165696 A1 WO2022165696 A1 WO 2022165696A1
Authority
WO
WIPO (PCT)
Prior art keywords
composition
acid
composition according
present
total weight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/CN2021/075212
Other languages
English (en)
Inventor
Yuan Ma
Yi Deng
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LOreal SA
Original Assignee
LOreal SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LOreal SA filed Critical LOreal SA
Priority to CN202180093037.1A priority Critical patent/CN116887803A/zh
Priority to PCT/CN2021/075212 priority patent/WO2022165696A1/fr
Priority to FR2102857A priority patent/FR3119324B1/fr
Publication of WO2022165696A1 publication Critical patent/WO2022165696A1/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/676—Ascorbic acid, i.e. vitamin C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/345—Alcohols containing more than one hydroxy group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/368—Carboxylic acids; Salts or anhydrides thereof with carboxyl groups directly bound to carbon atoms of aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/39—Derivatives containing from 2 to 10 oxyalkylene groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/817—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a single or double bond to nitrogen or by a heterocyclic ring containing nitrogen; Compositions or derivatives of such polymers, e.g. vinylimidazol, vinylcaprolactame, allylamines (Polyquaternium 6)
    • A61K8/8182—Copolymers of vinyl-pyrrolidones. Compositions of derivatives of such polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/008—Preparations for oily skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
    • A61K2800/30—Characterized by the absence of a particular group of ingredients
    • A61K2800/31—Anhydrous
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/75—Anti-irritant

Definitions

  • the present invention relates to a cosmetic composition.
  • the present invention relates to a composition for improving the appearance of keratin materials.
  • the present invention also relates to a non-therapeutic process for improving the appearance of keratin materials.
  • the blackhead is considered to be very bothersome, mainly because of its black or even brown colour, and more particularly so on only slightly pigmented skin. This unattractive skin disorder affects all skin types and is a major concern for consumers.
  • Cosmetic compositions exist for combating the appearance of blackheads or for concealing them, in particular on the face.
  • ablackhead is an open comedo (non-inflammatory lesion) characterized by a distended hair canal, sebum retention and excessive cornification of the pilosebaceous canal. Hypercornification leads to sebum retention and to the accumulation of cell debris.
  • inventions specifically relating to treating blackheads are known and act especially:
  • the present invention provides an anhydrous composition for improving the appearance of keratin materials, comprising:
  • composition according to the present invention comprising a combination of ingredients i) -iv) above can deliver a good brightening effect and blackhead removal effect, meanwhile it can result in a warming feeling without bringing irritation to keratin materials.
  • composition according to the present invention can be demonstrated instantly or in long-term.
  • composition according to the present invention has a suitable viscosity for topical application and is stable over time.
  • the present invention also provides a non-therapeutic process for improving the appearance of keratin materials, comprising applying the composition according to the present invention on the keratin materials for a period of time.
  • keratin materials means the entire skin of the body, excluding the scalp and mucous membranes.
  • the term “keratin materials” preferably concerns the skin of the face, in particular the skin of the forehead and/or of the sides of the nose and/or of the chin.
  • anhydrous it means that no water is added on purpose and the water content of the composition is less than 0.5 wt. %, particularly less than 0.1 wt. %, relative to the total weight of the composition. In particular, there is no water in the composition.
  • the present invention provides an anhydrous composition for improving the appearance of keratin materials, comprising:
  • composition according to the present invention is oil-free.
  • oil-free it means that the content of oil in the composition is less than 2 wt. %by weight, preferably the composition does not comprise any oil.
  • composition according to the present invention comprises ascorbic acid.
  • Ascorbic acid has the following structural formula:
  • Ascorbic acid can be extracted from various vegetable sources in which it occurs naturally, such as rose hips, blackcurrants, the juice of citrus fruits, and the ripe fruit of Capsicum annuum L.
  • a common synthetic procedure involves the hydrogenation of D-glucose to D-sorbitol, followed by oxidation using Acetobacter suboxydans to form L-sorbose.
  • a carboxyl group is then introduced at C1 by air oxidation of the diacetone derivative of Lsorbose and the resulting diacetone-2-keto-L-gulonic acid is converted to L-ascorbic acid by heating with hydrochloric acid.
  • the ascorbic acid is present in an amount ranging from 2 wt. %to 20 wt. %, preferably from 5 wt. %to 15 wt. %, more preferably from 8 wt. %to 12 wt. %, relative to the total weight of the composition.
  • composition according to the present invention comprises at least one peeling agent selected from salicylic acid and derivatives thereof.
  • the salicylic acid and derivatives thereof useful in the composition of the present invention can be represented by formula (I) below:
  • R represents a hydrogen atom or a linear, branched or cyclic aliphatic alkoxy, ester or ketoxy chain, these chains comprising from 2 to 22 carbon atoms and possibly being substituted with at least one substituent selected from halogen atom, a trifluoromethyl group and hydroxyl groups in free form or esterified with an acid containing from 1 to 6 carbon atoms or else with a carboxyl function which is free or esterified with a lower alcohol containing from 1 to 6 carbon atoms; and
  • R' represents a hydroxyl group or an ester function of formula (II) :
  • R 1 is a saturated or unsaturated aliphatic group containing from 1 to 18 carbon atoms.
  • the radical R comprises at least 4 carbon atoms. It is formed, for example, from a linear alkyl or alkoxy radical containing from 4 to 11 carbon atoms.
  • the peeling agent is selected from salicylic acid, capryloylsalicylic acid, 5-n-decanoylsalicylic acid and 5-n-dodecanoyl-salicylic acid and is in particular capryloylsalicylic acid.
  • the peeling agent is present in an amount ranging from 0.2 wt. %to 2 wt. %, preferably from 0.5 wt. %to 1.5 wt. %, more preferably from 0.8 wt. %to 1.2 wt. %, relative to the total weight of the composition.
  • the composition according to the present invention comprises at least one polyethylene glycol containing from 4 to 30-CH 2 CH 2 O-units.
  • polyethylene glycols also known as PEG are polyether compounds with a structure of formula (III) ,
  • n is an integer ranging from 4 to 30.
  • polyethylene glycols can be made of, for example, PEG-4, which is sold by the company BP with the trade name Breox PEG 200, PEG-6, which is sold by the company Dow Chemical under the trade name Carbowax Sentry PEG 300, PEG-8 (or polyethylene 400) , which is sold by the company BASF under the trade name E 400, PEG-12 sold by the company Dow Chemical under the name Carbowax Sentry Polyethylene Glycol 600NF, FCC Grade, PEG-20 sold by the company Dow Chemical under the name Carbowax Sentry Polyethylene Glycol 1000 NF, FCC Grade, or a mixture thereof.
  • PEG-4 which is sold by the company BP with the trade name Breox PEG 200
  • PEG-6 which is sold by the company Dow Chemical under the trade name Carbowax Sentry PEG 300
  • PEG-8 or polyethylene 400
  • E 400 polyethylene 400
  • PEG-12 sold by the company Dow Chemical under the name Carbowax Sentry Polyethylene Glycol 600NF, FCC Grade
  • the polyethylene glycols that are suitable for the present invention comprises from 6 to 20, more preferably from 8 to 12-CH 2 CH 2 O-units.
  • PEG-8 is used in the present invention.
  • the polyethylene glycol is present in an amount ranging from 20 wt. %to 70 wt. %, preferably from 25 wt. %to 60 wt. %, more preferably from 30 wt. %to 55 wt. %, relative to the total weight of the composition.
  • the composition according to the present invention comprises glycerin.
  • glycerin is present in an amount ranging from 10 wt. %to 80 wt. %, preferably from 20 wt. %to 60 wt. %, more preferably from 30 wt. %to 45 wt. %, relative to the total weight of the composition.
  • composition according to the present invention comprises at least one hydrophilic thickener.
  • hydrophilic gelling agents mention may be made more particularly of 2-acrylamido-2-methylpropanesulfonic acid (AMPS) homopolymers and copolymers.
  • AMPS 2-acrylamido-2-methylpropanesulfonic acid
  • 2-acrylamido-2-methylpropanesulfonic acid homopolymers mention can be made of, for example, ammonium 2-acrylamido-2-methylpropanesulfonate homopolymer, such as the product sold under the trade name Hostacerin by the company Clariant.
  • AMPS 2-acrylamido-2-methylpropanesulfonic acid
  • water-soluble or water-dispersible means polymers which, when introduced into an aqueous phase at 25°C, to a mass concentration equal to 1%, make it possible to obtain a macroscopically homogeneous and transparent solution, i.e. a solution that has a maximum light transmittance value, at a wavelength equal to 500 nm, through a sample 1 cm thick, of at least 60%and preferably of at least 70%.
  • the AMPS copolymers useful in accordance with the present invention are crosslinked or non-crosslinked copolymers comprising at least the acrylamido-2-methylpropanesulfonic acid monomer, in a form partially or totally neutralized with a mineral base such as ammonia, sodium hydroxide or potassium hydroxide.
  • They are preferably totally neutralized or virtually totally neutralized, i.e. at least 90%neutralized.
  • the crosslinking agents may be chosen from the polyolefinically unsaturated compounds commonly used for the crosslinking of polymers obtained by free-radical polymerization.
  • crosslinking agents examples include divinylbenzene, diallyl ether, dipropylene glycol diallyl ether, polyglycol diallyl ethers, triethylene glycol divinyl ether, hydroquinone diallyl ether, ethylene glycol or tetraethylene glycol di (meth) acrylate, trimethylolpropane triacrylate, methylenebisacrylamide, methylenebismethacrylamide, triallylamine, triallyl cyanurate, diallyl maleate, tetraallylethylenediamine, tetraallyloxyethane, trimethylolpropane diallyl ether, allyl (meth) acrylate, allylic ethers of alcohols of the sugar series, or other allylic or vinyl ethers of polyfunctional alcohols, and also allylic esters of phosphoric and/or vinylphosphonic acid derivatives, or mixtures of these compounds.
  • the crosslinking agent is chosen from methylenebis-acrylamide, allyl methacrylate and trimethylolpropane triacrylate (TMPTA) .
  • TMPTA trimethylolpropane triacrylate
  • the degree of crosslinking generally ranges from 0.01 mol%to 10 mol%and more particularly from 0.2 mol%to 2 mol%relative to the polymer.
  • the water-soluble or water-dispersible AMPS copolymers according to the present invention contain a nonionic water-soluble comonomer.
  • nonionic water-soluble comonomers examples that may be mentioned include:
  • N-vinyllactams comprising a cyclic alkyl group containing 4 to 9 carbon atoms, such as N-vinylpyrrolidone, N-butyrolactam and N-vinylcaprolactam,
  • - R 15 is chosen from H, -CH 3 , -C 2 H 5 and-C 3 H 7 ,
  • - X 2 is chosen from alkyl ethers of -OR 16 type in which R 16 is a linear or branched, saturated or unsaturated hydrocarbon-based radical containing from 1 to 6 carbons, optionally substituted with a halogen atom (iodine, bromine, chlorine or fluorine) ; a hydroxyl group (-OH) ; ether.
  • R 16 is a linear or branched, saturated or unsaturated hydrocarbon-based radical containing from 1 to 6 carbons, optionally substituted with a halogen atom (iodine, bromine, chlorine or fluorine) ; a hydroxyl group (-OH) ; ether.
  • the AMPS homopolymers and copolymers preferably have a molar mass ranging from 50 000 g/mol to 10 000 000 g/mol, preferably from 80 000 g/mol to 8 000 000 g/mol and even more preferably from 100 000 g/mol to 7 000 000 g/mol.
  • AMPS copolymers in accordance with the present invention include:
  • the hydrophilic thickener is selected from copolymers of AMPS and of vinylpyrrolidone or of vinylformamide, optionally partially or totally neutralized with a mineral base such as ammonia, sodium hydroxide or potassium hydroxide.
  • a mineral base such as ammonia, sodium hydroxide or potassium hydroxide.
  • the hydrophilic thickener is present in the composition according to the present invention in an amount ranging from 0.1 wt. %to 3 wt. %, preferably from 0.2 wt. %to 2 wt. %, more preferably from 0.3 wt. %to 1 wt. %of the total weight of the composition.
  • composition of the present invention may comprise an additional cosmetic active ingredient in addition to ascorbic acid and peeling agent as defined previously.
  • moisturizing agents such as protein hydrolysates; natural extracts; vitamins such as vitamin A (retinol) , vitamin E (tocopherol) , vitamin B5 (panthenol) , vitamin B3 (niacinamide) , and derivatives of said vitamins (in particular esters) and mixtures thereof; urea; caffeine; alpha-hydroxyacids such as lactic acid or glycolic acid and derivatives thereof; retinoids such as carotenoids and derivatives of vitamin A; sunscreens; extracts from algae, fungi, plants, yeasts and bacteria; enzymes; tightening agents; agents acting on the microcirculation, hydrating agent such as propylene glycol, and mixtures thereof.
  • moisturizing agents such as protein hydrolysates; natural extracts; vitamins such as vitamin A (retinol) , vitamin E (tocopherol) , vitamin B5 (panthenol) , vitamin B3 (niacinamide) , and derivatives of said vitamins (in particular esters) and
  • composition of the present invention may also contain conventional cosmetic adjuvants or additives, for instance fragrances, additional thickeners, pH regulators (for example, triethanolamine, citric acid and sodium hydroxide) , fillers (for examples aluminum starch octenylsuccinate and polymethiylsisesquioxane) and mixtures thereof.
  • fragrances for instance, fragrances, additional thickeners, pH regulators (for example, triethanolamine, citric acid and sodium hydroxide) , fillers (for examples aluminum starch octenylsuccinate and polymethiylsisesquioxane) and mixtures thereof.
  • additional thickeners for example, triethanolamine, citric acid and sodium hydroxide
  • fillers for examples aluminum starch octenylsuccinate and polymethiylsisesquioxane
  • the composition of the present invention comprises a filler selected from aluminum starch octenylsuccinate, polymethiylsisesquioxane, a mixture thereof to further decrease the stickiness.
  • the present invention relates to an anhydrous composition for improving the appearance of keratin materials, comprising, relative to the total weight of the composition:
  • hydrophilic thickener selected from copolymers of AMPS and of vinylpyrrolidone or of vinylformamide, optionally partially or totally neutralized with a mineral base such as ammonia, sodium hydroxide or potassium hydroxide;
  • composition is oil-free.
  • oil-free it means that no oil is added into the composition according to the present invention on purpose and the composition comprises no more than 2.0 wt. %of oil, preferably no more than 0.5 wt. %of oil, relative to the total weight of the composition.
  • the viscosity of the composition according to the present invention can be measured at 25 C, using a Rheomat 100 Plus viscometer equipped with a spindle M2 rotating at 200 rpm.
  • the composition of the present invention has a viscosity of from 50 UD (Deviation Units) to 100 UD, preferably from 60 UD to 100 UD, measured at 25°C using a Rheomat 100 Plus viscometer equipped with a spindle M2 rotating at 200 rpm.
  • composition of the present invention is stable various temperatures, for example at least from 4°C to 45°C, for at least 2 months, and is stable after a temperature cycling from-20°C to 20°C for at least 10 days.
  • composition according to the present invention is intended for topical application.
  • the present invention relates to a non-therapeutic process for improving the appearance of keratin materials, comprising applying the composition according to the present invention on the keratin materials for a period of time.
  • compositions of comparative examples (CE. ) 1-2 and invention examples (IE. ) 1-5 were prepared according to the amounts given in Table 2. The amount of each component is given in%by weight of the total weight of the composition.
  • compositions were prepared as follows, taking the composition of Invention Example 1 as an example:
  • AMMONIUM ACRYLOYLDIMETHYLTAURATE/VP COPOLYMER was added to the main tank and dispersed;
  • compositions obtained above were evaluated as follows.
  • the viscosity of each composition was measured at 25°C, using a Rheomat 100 Plus viscometer equipped with a M2 spindle, the measurement being performed after 10 minutes of rotation of the spindle in the composition (after which time stabilization of the viscosity and of the spin speed of the spindle are observed) , at a shear rate of 200 rpm.
  • the stability will be evaluated as PASS if its appearance does not change after all of the stability tests at different temperature and that cycle stability test, otherwise, it will be evaluated as FAILED.
  • the irritation risk was evaluated as follows:
  • the opacity value was measured with an opacitometer. Then, the permeability value was determined with an UV-meter after applying sodium fluorescein on one side of the corneas. The in-vitro irritancy score was calculated based on the opacity and the permeability.
  • IVIS opacity value+ (15 x permeability value)
  • the irritation risk was classified based on the irritancy score according to the following standards.
  • the warming feeling was evaluated as follows:
  • compositions of invention formula 3, comparative formulas 1 and 2 were further evaluated on the blackhead removability as follows.
  • composition according to the present invention has a blackhead removal effect, meanwhile it can result in a warming feeling without bringing irritation to keratin materials.
  • composition according to the present invention has a suitable viscosity for topical application and is stable over time.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

L'invention concerne une composition anhydre pour améliorer l'aspect de matières kératiniques, comprenant : i) de l'acide ascorbique; ii) au moins un agent de dermabrasion sélectionné parmi l'acide salicylique et des dérivés de celui-ci; iii) au moins un polyéthylène glycol contenant de 4 à 30 unités -CH2CH2O-; iv) de la glycérine; et v) au moins un épaississant hydrophile, L'invention concerne également un procédé non thérapeutique pour améliorer l'aspect de matières kératiniques, comprenant l'application de la composition sur les matières kératiniques pendant une certaine durée.
PCT/CN2021/075212 2021-02-04 2021-02-04 Composition pour améliorer l'aspect de matières kératiniques Ceased WO2022165696A1 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
CN202180093037.1A CN116887803A (zh) 2021-02-04 2021-02-04 用于改善角蛋白材料外观的组合物
PCT/CN2021/075212 WO2022165696A1 (fr) 2021-02-04 2021-02-04 Composition pour améliorer l'aspect de matières kératiniques
FR2102857A FR3119324B1 (fr) 2021-02-04 2021-03-23 Composition pour améliorer l’aspect des matières kératineuses

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/CN2021/075212 WO2022165696A1 (fr) 2021-02-04 2021-02-04 Composition pour améliorer l'aspect de matières kératiniques

Publications (1)

Publication Number Publication Date
WO2022165696A1 true WO2022165696A1 (fr) 2022-08-11

Family

ID=82655396

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2021/075212 Ceased WO2022165696A1 (fr) 2021-02-04 2021-02-04 Composition pour améliorer l'aspect de matières kératiniques

Country Status (3)

Country Link
CN (1) CN116887803A (fr)
FR (1) FR3119324B1 (fr)
WO (1) WO2022165696A1 (fr)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998058628A1 (fr) * 1997-06-20 1998-12-30 Mary Kay Inc. Composition cosmetique renfermant un agent de blanchiment et un desquamant
WO2002045662A2 (fr) * 2000-12-06 2002-06-13 Imaginative Research Associates, Inc. Cremes, lotions et gels anhydres
US20090232756A1 (en) * 2008-03-11 2009-09-17 L'oreal Cosmetic composition comprising an ascorbic acid or salicylic acid compound
WO2010105050A1 (fr) * 2009-03-11 2010-09-16 Isp Investments Inc. Compositions d'additif épaississant
CN111542305A (zh) * 2017-12-26 2020-08-14 莱雅公司 用于护理角蛋白材料的组合物、其方法和用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040081672A1 (en) * 2002-10-25 2004-04-29 Gupta Shyam K. Niacinamide, niacin, and niacin esters based delivery systems for treating topical disorders of skin and skin aging
EP2010132A1 (fr) * 2006-04-18 2009-01-07 DSMIP Assets B.V. Compositions cosmetiques comprenant de l'acide salicylique et de l'acide ascorbique
FR3060352B1 (fr) * 2016-12-21 2020-11-06 Oreal Composes phosphates comme anti-infrarouge
FR3075609B1 (fr) * 2017-12-21 2020-05-22 L'oreal Compositions comprenant de l’acide salicylique ou l’un de ses derives, un tensioactif possedant un hlb superieur ou egal a 9,7, et au moins un polymere epaississant
CN108158993A (zh) * 2018-01-12 2018-06-15 连云港本草美汇医药科技有限公司 一种祛痘控油微乳凝胶剂及其制备方法与应用
CN107998000A (zh) * 2018-02-01 2018-05-08 南京信息工程大学 一种祛痘面霜及其制备方法

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998058628A1 (fr) * 1997-06-20 1998-12-30 Mary Kay Inc. Composition cosmetique renfermant un agent de blanchiment et un desquamant
WO2002045662A2 (fr) * 2000-12-06 2002-06-13 Imaginative Research Associates, Inc. Cremes, lotions et gels anhydres
US20090232756A1 (en) * 2008-03-11 2009-09-17 L'oreal Cosmetic composition comprising an ascorbic acid or salicylic acid compound
WO2010105050A1 (fr) * 2009-03-11 2010-09-16 Isp Investments Inc. Compositions d'additif épaississant
CN111542305A (zh) * 2017-12-26 2020-08-14 莱雅公司 用于护理角蛋白材料的组合物、其方法和用途

Also Published As

Publication number Publication date
FR3119324A1 (fr) 2022-08-05
FR3119324B1 (fr) 2024-02-09
CN116887803A (zh) 2023-10-13

Similar Documents

Publication Publication Date Title
US11583488B2 (en) Method of improving penetration of a vitamin B3 compound into skin
JPH1171405A (ja) 新規なスクレログルカンおよびその新規化合物を含有する化粧品組成物
CN111481465B (zh) 一种抗坏血酸保护剂及其应用
US9913788B2 (en) Oil-in-water emulsion composition
CN113181080A (zh) 磷酰胆碱聚合物的透明油溶液及其制法和应用
CN116139064B (zh) 一种防晒增效组合物及其应用和化妆品
JPH06199628A (ja) ポリエトキシ化ビタミンｅを含有する化粧料組成物
WO2019170502A1 (fr) Composition topique
US20030215413A1 (en) Compositions containing stabilized retinoid
CN112315866A (zh) 一种黑色植物提取物及其应用
CN108451790B (zh) 一种含亲水性角蛋白的保湿精华液及其制备方法
WO2022165696A1 (fr) Composition pour améliorer l'aspect de matières kératiniques
WO2022087666A1 (fr) Compositions de rétinol, leurs procédés de préparation et d'utilisation
JP7543827B2 (ja) 皮膚化粧料
CN114288201A (zh) 一种祛眼袋、淡化黑眼圈的组合物及其制备方法和应用
JPH05345717A (ja) 皮膚化粧料
CN115068389B (zh) 一种多效组合物、精华霜及其制备方法
CN114712277B (zh) 一种保湿修复组合物和化妆品及制备方法
EP4333796B1 (fr) Composition destinée au soin des matières kératiniques
CN115400067A (zh) 用于皮肤的美白组合物
JP2023128267A (ja) 皮膚化粧料
JPH05345714A (ja) 皮膚化粧料
JPH05345716A (ja) 皮膚化粧料
EP4267091A1 (fr) Composition pour soin des matières kératiniques
CN107569436B (zh) 一种护肤组合物、柔肤水及其制备方法

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 21923721

Country of ref document: EP

Kind code of ref document: A1

WWE Wipo information: entry into national phase

Ref document number: 202180093037.1

Country of ref document: CN

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 21923721

Country of ref document: EP

Kind code of ref document: A1